Related Experiment Video
Updated: Jul 16, 2026

Contractility Measurements of Human Uterine Smooth Muscle to Aid Drug Development
Published on: January 26, 2018
Myometrial dysplasia (atypical myometrial hyperplasia)
Stewart F Cramer1, Patricia M Newcomb, Thomas A Bonfiglio
1Department of Pathology, Rochester General Hospital, University of Rochester School of Medicine, Rochester, NY 14621, USA. stewart.cramer@viahealth.org
Abstract:
Although precursor lesions are well known for cervical and endometrial neoplasms, precursor lesions are not currently recognized for the most common tumor of the uterus-leiomyomas. Myometrial hyperplasia has been recently described and evaluated by morphometry, but its relationship to uterine leiomyomas has not been systematically explored. Myometrial dysplasia (atypical myometrial hyperplasia) has not been previously recognized. We herein report a case of myometrial dysplasia with immunostains for proliferation marker MIB-1 (Ki-67) and for p53. The paradoxical rarity of myometrial dysplasia is considered in comparison to the striking frequency of uterine leiomyomas.
Related Concept Videos
Cellular Adaptation IV: Dysplasia and Metaplasia
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy I: Introduction and Classification
Cellular Adaptation III: Hyperplasia
Histology of the Uterus
The endometrium is the...
Mitral Valve Prolapse I: Introduction
